San Diego, CA, United States of America

Loui Madakamutil



Average Co-Inventor Count = 18.0

ph-index = 3

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Loui Madakamutil

Introduction

Loui Madakamutil is an esteemed inventor based in San Diego, California, recognized for his significant contributions to the field of pharmaceuticals and oncology. With a total of three patents to his name, Loui has developed groundbreaking solutions targeting critical pathways involved in cancer development and treatment.

Latest Patents

Loui's latest patents include an innovative Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor, specifically designed to address oncology indications and diseases associated with the mTOR/PI3K/AKT pathway. This invention comprises heteroaryl compounds that possess structural properties aimed at inhibiting mTOR kinase, thereby contributing to advanced therapeutic strategies in cancer care.

Career Highlights

Currently, Loui is employed at Signal Pharmaceuticals, Inc., a company known for its dedication to delivering innovative treatments for complex diseases. His work in drug development and design has positioned him as a valuable asset in the scientific community, particularly in the fight against cancer.

Collaborations

Throughout his career, Loui has collaborated with many talented professionals, including his colleagues Sophie Perrin-Ninkovic and Roy Leonard Harris, III. These collaborative efforts have been instrumental in advancing their collective research and enhancing the effectiveness of their innovations.

Conclusion

Loui Madakamutil exemplifies the spirit of innovation in the pharmaceutical sector. His ongoing commitment to developing effective therapeutic solutions signifies a promising advancement in oncology treatment, ultimately benefitting patients worldwide. By harnessing innovative compounds and collaborating with skilled professionals, Loui continues to pave the way for future breakthroughs in health care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…